NCT01783613View on ClinicalTrials.gov

Eficacy of Long-term Suplementation With Docosahexaenoic Acid in Patients With Cystic Fibrosis

NACompletedINTERVENTIONAL
Enrollment

96

Participants

Timeline

Start Date

October 31, 2011

Primary Completion Date

January 31, 2015

Study Completion Date

January 31, 2015

Conditions
Cystic Fibrosis
Interventions
DIETARY_SUPPLEMENT

Docosahexaenoic acid administration: 50 mg/kg/day during 12 months

DIETARY_SUPPLEMENT

Placebo: 50 mg/kg/day during 12 months

Trial Locations (5)

28034

Ramón y Cajal Hospital, Madrid

28041

Hospital 12 de Octubre, Madrid

33006

Hospital Universitario Central de Asturias, Oviedo

46026

Hospital Universitari i Politecnic La FE, Valencia

Unknown

Hospital Universitario La Princesa, Madrid

All Listed Sponsors
lead

Fundacion para la Investigacion Biomedica del Hospital Universitario Ramon y Cajal

OTHER

NCT01783613 - Eficacy of Long-term Suplementation With Docosahexaenoic Acid in Patients With Cystic Fibrosis | Biotech Hunter | Biotech Hunter